PureTech Management, Inc.
Records under this name other than patents PureTech Management, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to PureTech Management, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,238,643 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation Formerly held In force · High confidence | In force | High confidence | |
| US 10,265,311 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,369,143 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation Formerly held In force · High confidence | In force | High confidence | |
| US 10,369,144 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation Formerly held In force · High confidence | In force | High confidence | |
| US 10,695,339 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation Formerly held In force · High confidence | In force | High confidence | |
| US 11,975,029 | Compositions and Methods for Inhibition of Lineage Specific Proteins Formerly held In force · High confidence | In force | High confidence | |
| US 12,178,875 | Lymphatic System-Directing Lipid Prodrugs Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,344,091 | ANTI-GALECTIN-9 Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,450,374 | ANTI-GALECTIN-9 Antibodies and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,629,191 | ANTI-GALECTIN-9 Antibodies and Uses Thereof Formerly held In force · Low confidence | In force | Low confidence |